Davidson Capital Management Inc. Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Davidson Capital Management Inc. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,876 shares of the healthcare conglomerate’s stock after buying an additional 289 shares during the period. Davidson Capital Management Inc.’s holdings in UnitedHealth Group were worth $2,972,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the stock. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter worth about $30,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth about $37,000. Friedenthal Financial acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $51,000. Highline Wealth Partners LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth approximately $55,000. Finally, Legacy Investment Solutions LLC acquired a new position in shares of UnitedHealth Group in the third quarter worth $57,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.1 %

Shares of UNH stock opened at $533.99 on Wednesday. The company has a market capitalization of $491.42 billion, a P/E ratio of 34.45, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The business’s 50 day moving average is $527.67 and its two-hundred day moving average is $564.22.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.83 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.